United States Hereditary Genetic Testing Market to be Dominated by DNA Sequencing through 2028
The increasing incidence
of genetic disorders is expected to drive the growth of the United
States Hereditary Genetic Testing Market in the forecast period.
According to
TechSci Research report, “United States Hereditary
Genetic Testing Market –By Region, Competition Forecast, & Opportunities, 2018-2028,” the United States Hereditary
Genetic Testing market is
anticipated to grow at a steady rate in the forecast period, 2024-2028. This
can be ascribed to the growing prevalence of genetic disorders such as cystic
fibrosis, and sickle cell diseases along with an increase in the cases of
cancer, and genetic anomalies in newborns across the country. Similarly,
growing awareness of genetic testing for screening cancer, pre-natal genetic
screening the growing usage of NGS for the studies of different genetic
diseases will further drive the growth of the market during the forecasted
period. Additionally, growing healthcare infrastructure and support by the
government for the diagnosis of a genetic disease is expected to create
lucrative growth during the forecast period. Also, growing technological
advancement such as chromosomal microarray analysis and biochip for the
detection of genetic disorders is anticipated to boost the growth of the market
over the years.
However, standardization concerns of genetic
testing bases diagnostics may hamper the growth of the United States Hereditary Genetic Testing market in the forecast period. Additionally, stringent
regulatory requirements for product approvals across regions like north America
and South America may hamper the growth of the market during the forecast
period. Similarly, the high cost of DNA testing kits can hamper the US Hereditary
Genetic Testing market during the forecast period. Also, lack of skilled
professionals in the laboratory for managing the DNA analysis technique may
hamper the growth of the market over the years.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Hereditary Genetic Testing Market”
United States Hereditary
Genetic Testing Market
can be segmented by technique, application, payer, end user, region and
competitive landscape.
Based on Technique, the United States Hereditary Genetic Testing market
can be segmented into PCR, DNA Sequencing, Microarrays, and Others. The DNA
sequencing segment is expected to dominate
the market during the forecast period owing to the growing adoption of this
technique for conducting genetic tests. Additionally, growing demand for faster
analysis techniques and decreasing costs of the NGS technique is expected to
support the segmental growth. Similarly, the growing mutation detection in
genes is an important component for oncology genetic testing which will further be
driving the growth of the market during the forecast period.
Based on Application, the United States Hereditary Genetic
Testing Market can be
further segmented into Cardiology, Oncology, Pharmacogenomics, Cognitive
Dysfunction, Pathogenomics, and Others. The oncology segment dominated the market in
2022 and is expected to maintain its dominance throughout the forecast period. This
can be attributed to i the launch of new and technologically advanced genetic
tests by key players along with growing favorable reimbursement policies and
growing demand for better diagnosis due to the increasing incidence of cancer
across the country.
Major
companies operating in the United
States Hereditary Genetic Testing Market are:
- Invitae Corporation
- Ambry Genetics
- BioReference Laboratories Inc.
- Progenity Inc.
- Pathema Gx Labs, LLC.
- Quest Diagnostics Incorporated
- Myriad Genetics Inc.
- Fulgent Genetics, Inc.
- Burning Rock Biotech Limited.
In March 2021, GI OnDEMAND announced a
collaborated with Ambry Genetics to integrate online genetic counseling and
testing services into their nationwide gastroenterology practices and it can
identify hereditary GI cancer syndromes to guide through potentially
life-altering healthcare decisions.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“United States
Hereditary Genetic Testing Market is expected to register significant
growth during the forecast period on account of the increasing demand for
accurate and reliable data along with the growing adoption of advanced testing techniques
across the country. Similarly, the growing prevalence of chronic diseases such
as cardiovascular diseases, cancer, and other genetic diseases will further drive
the growth of the market during the forecast period. Additionally, the growing
demand for early and preventive care along with growing awareness about DNA
sequencing techniques among researchers and laboratory technicians is expected
to drive the growth of the market over the years. Besides, the presence of key
players providing the genetic tests, growing recommendations provided by
government agencies to ensure the quality of hereditary testing services is further
expected to increase the demand for
hereditary genetic testing market in the US.” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“United States Hereditary
Genetic Testing Market By Technique
(PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology,
Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others), By Payer (Public Health Insurance, Private Health Insurance, Out of
Pocket), By End User (Hospitals, Independent Laboratories), By Region, Competition Forecast & Opportunities, 2018-2028F,” has evaluated the future growth potential of United States Hereditary Genetic Testing Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United
States Hereditary Genetic Testing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com